Predictive Oncology arose as a joint venture between Skyline Medical and Helomics.

The Company Arose as a Joint Venture Between Skyline Medical and Helomics. Skyline Medical’s Automated ‘streamway’ System Transformed How Laboratories Safely Dispose of Medical Fluid Waste. By Joining Forces with Helomics, Predictive Oncology, Is Now Bringing Precision Medicine to the Diagnosis of Cancer. Harnessing the Power of Artificial Intelligence, Predictive Oncology Is Working with the Pharmaceutical, Diagnostic and Biotech Industries to Develop Highly Customizable Assessment Methods for Cancer Patients, Leading to Much More Effective Treatments.